Cargando…

Metabolic pathway engineering using the central signal processor P(II)

BACKGROUND: P(II) signal processor proteins are wide spread in prokaryotes and plants where they control a multitude of anabolic reactions. Efficient overproduction of metabolites requires relaxing the tight cellular control circuits. Here we demonstrate that a single point mutation in the P(II) sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Watzer, Björn, Engelbrecht, Alicia, Hauf, Waldemar, Stahl, Mark, Maldener, Iris, Forchhammer, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660640/
https://www.ncbi.nlm.nih.gov/pubmed/26608263
http://dx.doi.org/10.1186/s12934-015-0384-4
_version_ 1782402842200375296
author Watzer, Björn
Engelbrecht, Alicia
Hauf, Waldemar
Stahl, Mark
Maldener, Iris
Forchhammer, Karl
author_facet Watzer, Björn
Engelbrecht, Alicia
Hauf, Waldemar
Stahl, Mark
Maldener, Iris
Forchhammer, Karl
author_sort Watzer, Björn
collection PubMed
description BACKGROUND: P(II) signal processor proteins are wide spread in prokaryotes and plants where they control a multitude of anabolic reactions. Efficient overproduction of metabolites requires relaxing the tight cellular control circuits. Here we demonstrate that a single point mutation in the P(II) signaling protein from the cyanobacterium Synechocystis sp. PCC 6803 is sufficient to unlock the arginine pathway causing over accumulation of the biopolymer cyanophycin (multi-l-arginyl-poly-l-aspartate). This product is of biotechnological interest as a source of amino acids and polyaspartic acid. This work exemplifies a novel approach of pathway engineering by designing custom-tailored P(II) signaling proteins. Here, the engineered Synechocystis sp. PCC6803 strain with a P(II)-I86N mutation over-accumulated arginine through constitutive activation of the key enzyme N-acetylglutamate kinase (NAGK). RESULTS: In the engineered strain BW86, in vivo NAGK activity was strongly increased and led to a more than tenfold higher arginine content than in the wild-type. As a consequence, strain BW86 accumulated up to 57 % cyanophycin per cell dry mass under the tested conditions, which is the highest yield of cyanophycin reported to date. Strain BW86 produced cyanophycin in a molecular mass range of 25 to >100 kDa; the wild-type produced the polymer in a range of 30 to >100 kDa. CONCLUSIONS: The high yield and high molecular mass of cyanophycin produced by strain BW86 along with the low nutrient requirements of cyanobacteria make it a promising means for the biotechnological production of cyanophycin. This study furthermore demonstrates the feasibility of metabolic pathway engineering using the P(II) signaling protein, which occurs in numerous bacterial species. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-015-0384-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4660640
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46606402015-11-27 Metabolic pathway engineering using the central signal processor P(II) Watzer, Björn Engelbrecht, Alicia Hauf, Waldemar Stahl, Mark Maldener, Iris Forchhammer, Karl Microb Cell Fact Research BACKGROUND: P(II) signal processor proteins are wide spread in prokaryotes and plants where they control a multitude of anabolic reactions. Efficient overproduction of metabolites requires relaxing the tight cellular control circuits. Here we demonstrate that a single point mutation in the P(II) signaling protein from the cyanobacterium Synechocystis sp. PCC 6803 is sufficient to unlock the arginine pathway causing over accumulation of the biopolymer cyanophycin (multi-l-arginyl-poly-l-aspartate). This product is of biotechnological interest as a source of amino acids and polyaspartic acid. This work exemplifies a novel approach of pathway engineering by designing custom-tailored P(II) signaling proteins. Here, the engineered Synechocystis sp. PCC6803 strain with a P(II)-I86N mutation over-accumulated arginine through constitutive activation of the key enzyme N-acetylglutamate kinase (NAGK). RESULTS: In the engineered strain BW86, in vivo NAGK activity was strongly increased and led to a more than tenfold higher arginine content than in the wild-type. As a consequence, strain BW86 accumulated up to 57 % cyanophycin per cell dry mass under the tested conditions, which is the highest yield of cyanophycin reported to date. Strain BW86 produced cyanophycin in a molecular mass range of 25 to >100 kDa; the wild-type produced the polymer in a range of 30 to >100 kDa. CONCLUSIONS: The high yield and high molecular mass of cyanophycin produced by strain BW86 along with the low nutrient requirements of cyanobacteria make it a promising means for the biotechnological production of cyanophycin. This study furthermore demonstrates the feasibility of metabolic pathway engineering using the P(II) signaling protein, which occurs in numerous bacterial species. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-015-0384-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-25 /pmc/articles/PMC4660640/ /pubmed/26608263 http://dx.doi.org/10.1186/s12934-015-0384-4 Text en © Watzer et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Watzer, Björn
Engelbrecht, Alicia
Hauf, Waldemar
Stahl, Mark
Maldener, Iris
Forchhammer, Karl
Metabolic pathway engineering using the central signal processor P(II)
title Metabolic pathway engineering using the central signal processor P(II)
title_full Metabolic pathway engineering using the central signal processor P(II)
title_fullStr Metabolic pathway engineering using the central signal processor P(II)
title_full_unstemmed Metabolic pathway engineering using the central signal processor P(II)
title_short Metabolic pathway engineering using the central signal processor P(II)
title_sort metabolic pathway engineering using the central signal processor p(ii)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660640/
https://www.ncbi.nlm.nih.gov/pubmed/26608263
http://dx.doi.org/10.1186/s12934-015-0384-4
work_keys_str_mv AT watzerbjorn metabolicpathwayengineeringusingthecentralsignalprocessorpii
AT engelbrechtalicia metabolicpathwayengineeringusingthecentralsignalprocessorpii
AT haufwaldemar metabolicpathwayengineeringusingthecentralsignalprocessorpii
AT stahlmark metabolicpathwayengineeringusingthecentralsignalprocessorpii
AT maldeneriris metabolicpathwayengineeringusingthecentralsignalprocessorpii
AT forchhammerkarl metabolicpathwayengineeringusingthecentralsignalprocessorpii